Terms: = Breast cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Prognosis
17 results:
1. Automated quantification of stromal tumour infiltrating lymphocytes is associated with prognosis in breast cancer.
Gonzàlez-Farré M; Gibert J; Santiago-Díaz P; Santos J; García P; Massó J; Bellosillo B; Lloveras B; Albanell J; Vázquez I; Comerma L
Virchows Arch; 2023 Nov; 483(5):655-663. PubMed ID: 37500796
[TBL] [Abstract] [Full Text] [Related]
2. Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative breast cancer.
Nederlof I; Voorwerk L; Kok M
Clin Cancer Res; 2023 Jul; 29(13):2362-2370. PubMed ID: 36622327
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy.
Okcu O; Öztürk SD; Öztürk Ç; Şen B; Yasin Aİ; Bedir R
Ann Diagn Pathol; 2022 Jun; 58():151930. PubMed ID: 35245821
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical Expressions of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive breast cancer.
Park MH; Choi JE; Kim JR; Bae YK
Pathol Oncol Res; 2021; 27():1609795. PubMed ID: 34267603
[TBL] [Abstract] [Full Text] [Related]
5. A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
Polley MC; Leon-Ferre RA; Leung S; Cheng A; Gao D; Sinnwell J; Liu H; Hillman DW; Eyman-Casey A; Gilbert JA; Negron V; Boughey JC; Liu MC; Ingle JN; Kalari K; Couch F; Carter JM; Visscher DW; Nielsen TO; Goetz MP
Breast Cancer Res Treat; 2021 Feb; 185(3):557-566. PubMed ID: 33389409
[TBL] [Abstract] [Full Text] [Related]
6. Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative breast cancer.
Floris G; Richard F; Hamy AS; Jongen L; Wildiers H; Ardui J; Punie K; Smeets A; Berteloot P; Vergote I; De Croze D; Meseure D; Salomon A; Laé M; Reyal F; Biganzoli E; Neven P; Desmedt C
J Natl Cancer Inst; 2021 Feb; 113(2):146-153. PubMed ID: 33152071
[TBL] [Abstract] [Full Text] [Related]
7. Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis.
Jia R; Li Z; Liang W; Ji Y; Weng Y; Liang Y; Ning P
World J Surg Oncol; 2020 Oct; 18(1):268. PubMed ID: 33066779
[TBL] [Abstract] [Full Text] [Related]
8. A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer.
Van Berckelaer C; Van Geyt M; Linders S; Rypens C; Trinh XB; Tjalma WAA; Van Laere S; Colpaert C; Dirix L; van Dam PA
Breast; 2020 Oct; 53():212-220. PubMed ID: 32890963
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.
Pujani M; Jain H; Chauhan V; Agarwal C; Singh K; Singh M
Breast Dis; 2020; 39(2):61-69. PubMed ID: 32310155
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
Koletsa T; Kotoula V; Koliou GA; Manousou K; Chrisafi S; Zagouri F; Sotiropoulou M; Pentheroudakis G; Papoudou-Bai A; Christodoulou C; Xepapadakis G; Zografos G; Petraki K; Pazarli E; Koutras A; Kourea HP; Bafaloukos D; Chatzopoulos K; Iliadis A; Markopoulos C; Venizelos V; Arnogiannaki N; Kalogeras KT; Kostopoulos I; Gogas H; Fountzilas G
Cancer Immunol Immunother; 2020 Aug; 69(8):1549-1564. PubMed ID: 32303794
[TBL] [Abstract] [Full Text] [Related]
11. Usefulness of imaging findings in predicting tumor-infiltrating lymphocytes in patients with breast cancer.
Çelebi F; Agacayak F; Ozturk A; Ilgun S; Ucuncu M; Iyigun ZE; Ordu Ç; Pilanci KN; Alco G; Gultekin S; Cindil E; Soybir G; Aktepe F; Özmen V
Eur Radiol; 2020 Apr; 30(4):2049-2057. PubMed ID: 31822972
[TBL] [Abstract] [Full Text] [Related]
12. Effects of Age and Immune Landscape on Outcome in HER2-Positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials.
Chumsri S; Serie DJ; Li Z; Pogue-Geile KL; Soyano-Muller AE; Mashadi-Hossein A; Warren S; Lou Y; Colon-Otero G; Knutson KL; Perez EA; Moreno-Aspitia A; Thompson EA
Clin Cancer Res; 2019 Jul; 25(14):4422-4430. PubMed ID: 30808774
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive breast cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract] [Full Text] [Related]
14. [Correlation analysis of PD-L1 expression and prognosis in triple-negative breast cancers].
Pan BJ; Xu C; Ping GQ; Song GX; Zhang WM; Wang C; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):822-826. PubMed ID: 29224274
[No Abstract] [Full Text] [Related]
15. Comparison of a stable isotope labeled (sil) peptide and an extended sil peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
Adams S; Gray RJ; Demaria S; Goldstein L; Perez EA; Shulman LN; Martino S; Wang M; Jones VE; Saphner TJ; Wolff AC; Wood WC; Davidson NE; Sledge GW; Sparano JA; Badve SS
J Clin Oncol; 2014 Sep; 32(27):2959-66. PubMed ID: 25071121
[TBL] [Abstract] [Full Text] [Related]
17. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.
Ardizzoia A; Lissoni P; Brivio F; Tisi E; Perego MS; Grassi MG; Pittalis S; Crispino S; Barni S; Tancini G
J Biol Regul Homeost Agents; 1992; 6(3):103-7. PubMed ID: 1492596
[TBL] [Abstract] [Full Text] [Related]
